News

Efor Strengthens Its Global Ambitions With the Acquisition of Project Delivery Partners

6/02/2025

Following the integration of PharmEng Technology, Efor continues its growth with the acquisition of Project Delivery Partners. This second strategic move reaffirms our ambition to become a global leader in life sciences consulting by 2028. These acquisitions enhance our ability to deliver exceptional expertise to our clients while broadening our international footprint.

An Expanded Global Presence

Efor has strengthened its global presence by integrating Project Delivery Partners, bringing together over 3,000 professionals across 12 countries. This growth positions us to tackle the increasing challenges in the pharmaceutical, biotechnology and medical device sectors by combining local expertise with global perspective. The complementary strengths of Project Delivery Partners and PharmEng Technology enhance our ability to offer integrated solutions tailored to our clients’ needs worldwide.

Complementary Expertise to Better Serve Our Clients

PDP brings recognized expertise in CQV, Project Controls and Operational Readiness, perfectly complementing Efor’s diverse range of services. By combining these capabilities with PharmEng Technology’s strengths in Validation, Regulatory Affairs, and Quality Assurance, we enhance our ability to deliver comprehensive, end-to-end solutions across the entire lifecycle of healthcare products, with a global reach.

A Shared Vision and Values

“This new acquisition marks a turning point in our ambition to become a global leader”, says Mathieu Roger, Founding President of Efor. “By integrating Project Delivery Partners and PharmEng Technology, we are bringing together complementary expertise, creating greater value for our clients while unlocking new opportunities for our teams.”

A Unified Ambition

These two acquisitions highlight Efor’s commitment to staying ahead of industry trends, driving innovation, and delivering tailored solutions to address the challenges of the life sciences sector. We are building a dynamic group, ready to navigate the complexities of today’s global and regulated markets, with a strong focus on engagement, excellence, and collaboration.